SK Square Co Ltd
KRX:402340
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
75 200
324 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
SK Square Co Ltd
| Current Assets | 2.6T |
| Cash & Short-Term Investments | 2.1T |
| Receivables | 427.8B |
| Other Current Assets | 80B |
| Non-Current Assets | 24.6T |
| Long-Term Investments | 24T |
| PP&E | 187.5B |
| Intangibles | 271.5B |
| Other Non-Current Assets | 161.7B |
| Current Liabilities | 1.2T |
| Accounts Payable | 60.5B |
| Accrued Liabilities | 100.4B |
| Short-Term Debt | 14.9B |
| Other Current Liabilities | 1T |
| Non-Current Liabilities | 1.7T |
| Long-Term Debt | 62.2B |
| Other Non-Current Liabilities | 1.6T |
Balance Sheet
SK Square Co Ltd
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
642 184
|
1 001 595
|
1 270 887
|
1 366 630
|
|
| Cash Equivalents |
642 184
|
1 001 595
|
1 270 887
|
1 366 630
|
|
| Short-Term Investments |
1 023 720
|
408 732
|
239 684
|
178 805
|
|
| Total Receivables |
1 177 191
|
1 157 821
|
602 759
|
1 019 440
|
|
| Accounts Receivables |
450 731
|
526 439
|
251 621
|
242 483
|
|
| Other Receivables |
726 460
|
631 382
|
351 138
|
776 957
|
|
| Inventory |
37 073
|
116 500
|
113 263
|
42 247
|
|
| Other Current Assets |
86 995
|
180 128
|
61 930
|
95 651
|
|
| Total Current Assets |
2 967 163
|
2 864 776
|
2 288 523
|
2 702 773
|
|
| PP&E Net |
805 285
|
887 167
|
242 922
|
170 387
|
|
| PP&E Gross |
805 285
|
887 167
|
242 922
|
170 387
|
|
| Accumulated Depreciation |
1 058 462
|
1 183 406
|
373 815
|
329 876
|
|
| Intangible Assets |
1 100 267
|
1 163 487
|
240 785
|
213 098
|
|
| Goodwill |
1 403 098
|
1 462 259
|
272 481
|
263 803
|
|
| Note Receivable |
4 368
|
40 791
|
466 215
|
9 614
|
|
| Long-Term Investments |
16 136 622
|
15 568 420
|
14 293 618
|
18 403 358
|
|
| Other Long-Term Assets |
222 337
|
173 683
|
165 464
|
158 018
|
|
| Other Assets |
1 403 098
|
1 462 259
|
272 481
|
263 803
|
|
| Total Assets |
22 639 140
N/A
|
22 160 583
-2%
|
17 970 008
-19%
|
21 921 051
+22%
|
|
| Liabilities | |||||
| Accounts Payable |
230 077
|
259 918
|
95 911
|
84 050
|
|
| Accrued Liabilities |
445 906
|
271 672
|
133 266
|
114 023
|
|
| Short-Term Debt |
120 680
|
32 209
|
46 894
|
15 647
|
|
| Current Portion of Long-Term Debt |
77 402
|
81 245
|
33 945
|
23 132
|
|
| Other Current Liabilities |
1 643 300
|
1 174 486
|
1 070 589
|
1 159 493
|
|
| Total Current Liabilities |
2 517 365
|
1 819 530
|
1 380 605
|
1 396 345
|
|
| Long-Term Debt |
2 015 304
|
2 054 032
|
65 699
|
32 733
|
|
| Deferred Income Tax |
879 410
|
718 930
|
359 680
|
549 386
|
|
| Minority Interest |
194 939
|
343 648
|
614 688
|
552 882
|
|
| Other Liabilities |
371 767
|
404 891
|
347 507
|
357 172
|
|
| Total Liabilities |
5 978 785
N/A
|
5 341 031
-11%
|
2 768 179
-48%
|
2 888 518
+4%
|
|
| Equity | |||||
| Common Stock |
14 147
|
14 147
|
14 147
|
14 147
|
|
| Retained Earnings |
368 760
|
758 809
|
320 369
|
3 908 275
|
|
| Additional Paid In Capital |
15 805 933
|
15 935 459
|
14 812 069
|
14 818 889
|
|
| Unrealized Security Profit/Loss |
414 309
|
75 271
|
12 796
|
51 084
|
|
| Treasury Stock |
0
|
7 070
|
161 165
|
117 508
|
|
| Other Equity |
57 206
|
193 478
|
229 205
|
459 814
|
|
| Total Equity |
16 660 355
N/A
|
16 819 552
+1%
|
15 201 829
-10%
|
19 032 533
+25%
|
|
| Total Liabilities & Equity |
22 639 140
N/A
|
22 160 583
-2%
|
17 970 008
-19%
|
21 921 051
+22%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
141
|
141
|
135
|
133
|
|